Skip to content
Abierto

Vendor, San Diego, CA

Nanocomposix, Inc.

UEI EVQMBF7KC8P3, CAGE 3ZAN8

3 awards and -$25,985 obligated between January 26, 2024 and July 8, 2025, 33% under full and open competition, against 3.0 offers on average where reported.

Sells to

Awarding agencies by dollars.

Centers for Disease Control and Prevention$0
National Institutes of Health-$960
Food and Drug Administration-$25,025

Industries

NAICS on the awards, by dollars.

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)NAICS 541715-$960
Research and Development in NanotechnologyNAICS 541713-$25,025

How it wins

Awards by competition, set-aside and type.

Not Competed Under SAP1
Full and Open Competition After Exclusion of Sources1
Competed Under SAP1
Small Business Set Aside - Total1
Purchase Order2
Definitive Contract1

Awards

Every award in the window, by dollars obligated.

ContractAwarding officeDescribed asObligated
75D30122P15630Purchase Order, January 26, 2024, Not Competed Under SAP, 1 offersCDC Office of Acquisition ServicesCenters for Disease Control and PreventionLateral Flow Assay DevicesNAICS 541713, PSC 6515$0
75N93020C00013Definitive Contract, July 8, 2025, Full and Open Competition After Exclusion of Sources, 7 offersNational Institutes of Health NiaidNational Institutes of HealthVaccines Enabling Hiv Prevention Targeting Germinal Center Enhancement with Engineered Slow Release NanoparticlesNAICS 541715, PSC AN12-$960
75F40122P00453Purchase Order, July 25, 2024, Competed Under SAP, 1 offersFDA Office of Acq Grant SVCSFood and Drug AdministrationProduction of Aunp for Drug Delivery to the CNS to Monitor Efficacy and SafetyNAICS 541713, PSC B529-$25,025
Places of performance
CaliforniaMaryland
Transactions
3 across 3 awards